100 related articles for article (PubMed ID: 11914639)
1. Growth inhibition of human melanoma tumor cells by the combination of sodium phenylacetate (NaPA) and substituted dextrans and one NaPA-dextran conjugate.
Gervelas C; Avramoglou T; Crépin M; Jozefonvicz J
Anticancer Drugs; 2002 Jan; 13(1):37-45. PubMed ID: 11914639
[TBL] [Abstract][Full Text] [Related]
2. Aponecrotic, antiangiogenic and antiproliferative effects of a novel dextran derivative on breast cancer growth in vitro and in vivo.
Di Benedetto M; Starzec A; Colombo BM; Briane D; Perret GY; Kraemer M; Crépin M
Br J Pharmacol; 2002 Apr; 135(8):1859-71. PubMed ID: 11959788
[TBL] [Abstract][Full Text] [Related]
3. Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice.
Di Benedetto M; Kourbali Y; Starzec A; Vassy R; Jozefonvicz J; Perret G; Crepin M; Kraemer M
Br J Cancer; 2001 Sep; 85(6):917-23. PubMed ID: 11556846
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition of MCF-7 tumor cell line by phenylacetate linked to functionalized dextran.
Frank L; Avramoglou T; Sainte-Catherine O; Jozefonvicz J; Kraemer M
J Biomater Sci Polym Ed; 2004; 15(10):1305-15. PubMed ID: 15559851
[TBL] [Abstract][Full Text] [Related]
5. Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.
Adam L; Crépin M; Isräel L
Cancer Res; 1997 Mar; 57(6):1023-9. PubMed ID: 9067263
[TBL] [Abstract][Full Text] [Related]
6. Cytostatic and pro-apoptotic effects of a novel phenylacetate-dextran derivative (NaPaC) on breast cancer cells in interactions with endothelial cells.
Malherbe S; Crépin M; Legrand C; Wei MX
Anticancer Drugs; 2004 Nov; 15(10):975-81. PubMed ID: 15514567
[TBL] [Abstract][Full Text] [Related]
7. Sodium phenylacetate (NaPa) improves the TAM effect on glioblastoma experimental tumors by inducing cell growth arrest and apoptosis.
Wei MX; Liu JM; Gadal F; Yi P; Liu J; Crepin M
Anticancer Res; 2007; 27(2):953-8. PubMed ID: 17465226
[TBL] [Abstract][Full Text] [Related]
8. Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.
Samid D; Shack S; Myers CE
J Clin Invest; 1993 May; 91(5):2288-95. PubMed ID: 8486788
[TBL] [Abstract][Full Text] [Related]
9. Sodium phenylacetate modulates the synthesis of autocrine and paracrine growth factors secreted by breast cancer cell lines.
Thibout D; Di Benedetto M; Kraemer M; Sainte-Catherine O; Derbin C; Crépin M
Anticancer Res; 1998; 18(4A):2657-61. PubMed ID: 9703924
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro.
Ferrandina G; Melichar B; Loercher A; Verschraegen CF; Kudelka AP; Edwards CL; Scambia G; Kavanagh JJ; Abbruzzese JL; Freedman RS
Cancer Res; 1997 Oct; 57(19):4309-15. PubMed ID: 9331092
[TBL] [Abstract][Full Text] [Related]
11. Anti-proliferative and antitumoral activities of a functionalized dextran (CMDBJ) on the 1205 L-U human tumor melanoma cells.
Bastias J; Wei MX; Huynh R; Chaubet F; Jozefonvicz J; Crepin M
Anticancer Res; 2002; 22(3):1603-13. PubMed ID: 12168844
[TBL] [Abstract][Full Text] [Related]
12. Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cells.
Sidell N; Wada R; Han G; Chang B; Shack S; Moore T; Samid D
Int J Cancer; 1995 Feb; 60(4):507-14. PubMed ID: 7829265
[TBL] [Abstract][Full Text] [Related]
13. Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells.
Prasanna P; Thibault A; Liu L; Samid D
J Neurochem; 1996 Feb; 66(2):710-6. PubMed ID: 8592143
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of human rhabdomyosarcoma cells by sodium phenylacetate and Tretinoin.
Górski GK; McMorrow LE; Donaldson MH
In Vitro Cell Dev Biol; 1993 Mar; 29A(3 Pt 1):189-91. PubMed ID: 8463182
[No Abstract] [Full Text] [Related]
15. Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative.
Di Benedetto M; Starzec A; Vassy R; Perret GY; Crépin M; Kraemer M
Br J Cancer; 2003 Jun; 88(12):1987-94. PubMed ID: 12799647
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines.
Melichar B; Ferrandina G; Verschraegen CF; Loercher A; Abbruzzese JL; Freedman RS
Clin Cancer Res; 1998 Dec; 4(12):3069-76. PubMed ID: 9865922
[TBL] [Abstract][Full Text] [Related]
17. Sodium phenylacetate (NaPa) induces modifications of the proliferation, the adhesion and the cell cycle of tumoral epithelial breast cells.
Thibout D; Kraemer M; Di Benedetto M; Saffar L; Gattegno L; Derbin C; Crépin M
Anticancer Res; 1999; 19(3A):2121-6. PubMed ID: 10470159
[TBL] [Abstract][Full Text] [Related]
18. A new phenylacetate-bisphosphonate inhibits breast cancer cell growth by proapoptotic and antiangiogenic effects.
Sebbah-Louriki M; Colombo BM; el Manouni D; Martin A; Salzmann JL; Leroux Y; Perret GY; Crépin M
Anticancer Res; 2002; 22(6C):3925-31. PubMed ID: 12553014
[TBL] [Abstract][Full Text] [Related]
19. Radiopotentiation of human brain tumor cells by sodium phenylacetate.
Ozawa T; Lu RM; Hu LJ; Lamborn KR; Prados MD; Deen DF
Cancer Lett; 1999 Aug; 142(2):139-46. PubMed ID: 10463769
[TBL] [Abstract][Full Text] [Related]
20. Decrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive molecules.
Vasse M; Thibout D; Paysant J; Legrand E; Soria C; Crépin M
Br J Cancer; 2001 Mar; 84(6):802-7. PubMed ID: 11259095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
